How can we assess outcomes of clinical trials: The MCID Approach

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 3, 2007, Pages 191-194

  Make, Barry ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

COPD; Exercise; Minimal clinically important difference; Outcomes; Quality of life

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; CONFERENCE PAPER; EXERCISE TEST; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE;

ACTIVITIES OF DAILY LIVING; CLINICAL TRIALS AS TOPIC; EXERCISE TOLERANCE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 34548324381     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550701471231     Document Type: Conference Paper

References (18)

1. Kaplan RM, Ries AL. Quality of life: Concept and definition. J COPD 2007 (In press).
2. Jones PW. Activity limitation and quality of life in COPD. J COPD; 2007 (In press) .
3. Berry MJ. The relationship between exercise tolerance and other outcomes in COPD. J COPD; 2007 (In press).
4. Cohen J. Statistical power analysis for the behavioural sciences. London, England: Academic Press; 1969.
5. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10:407-415.
6. Man-Son-Hing M, Laupacis A, O'Rourke K, Molnar FJ, Mahon J, Chan KB, Wells G. Determination of the clinical importance of study results. J Gen Intern Med 2002; 17:469-476.
7. Sloan JA. Assessing the minimally clinically significant difference: Scientific considerations, challenges, and solutions. J COPD 2005; 2:57-62.
8. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002; 77:371-383.
9. Leidy NK, Wyrwich KW. Bridging the gap: Using triangulation methodology to estimate minimal clinically important differences (MCIDs). J COPD 2005; 2:157-165.
10. Make B, Casaburi R, Leidy NK. Interpreting results from clinical trials: Understanding minimal clinically important differences in COPD outcomes. J COPD 2005; 2:1-5.
11. Jones PW. St. George's respiratory questionnaire: MCID. J COPD 2005; 2:75-79.
12. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 2003; 41:582-592.
13. Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, Brooks P, Tugwell P. Minimal clinically important differences: Review of methods. J Rheumatol 2001; 28:406-412.
14. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting a sem-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999; 52:861-873.
15. Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. J COPD 2005; 2:63-67.
16. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155:1278-1282.
17. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 1996; 49:1215-1219.
18. Wyrwich KW, Fihn SD, Tierney WM, Kroenke K, Babu AN, Wolinsky FD. Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: An expert consensus panel report. J Gen Intern Med 2003; 18:196-202.